Karen-Lise Spindler

16PUBLICATIONS
41CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Other Asian literature (excl. South-East Asian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 11, 2026
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report.

|Dec 02, 2025
Longitudinal assessment of quality of life and symptom burden in locally advanced rectal cancer patients receiving IMRT-based preoperative radiotherapy: A prospective cohort study.

Christina G Truelsen, Camilla S Kronborg, Anne Ramlov

|Sep 19, 2025
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST.

Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen

|Sep 16, 2025
Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy.

Katrine Smedegaard Storm, Karen-Lise Garm Spindler, Gitte Fredberg Persson

|Sep 22, 2023
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE study.

Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen

|Jul 28, 2023
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer.

Martin P Nilsson, Christine Undseth, Per Albertsson

Pageof 3

Frequent Collaborators

3 joint publications

Louise Bach Callesen

3 joint publications

Eva Serup-Hansen

3 joint publications

Camilla S Kronborg

2 joint publications

Jens Overgaard